Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

ClinicalTrials.gov ID: NCT03682302

Public ClinicalTrials.gov record NCT03682302. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 3:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postsurgical Analgesia in Pediatric Subjects Aged 6 to Less Than 17 Years

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary Objective: To evaluate the pharmacokinetics (PK) of EXPAREL in pediatric subjects aged 6 to less than 17 years undergoing various types of surgeries. Secondary Objective: To evaluate the safety of EXPAREL in pediatric subjects aged 6 to less than 17 years undergoing various types of surgeries.

Study identification

NCT ID
NCT03682302
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pacira Pharmaceuticals, Inc
Industry
Enrollment
98 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2, 2019 (Actual)
Primary completion
Aug 30, 2019 (Actual)
Completion
Sep 24, 2019 (Actual)
Last update posted
Jan 6, 2021

2019

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Loma Linda University Loma Linda California 92354 —
Shriners Hospitals for Children, Northern California Sacramento California 95817 —
Stanford University Stanford California 94305 —
Children's Hospital Colorado Aurora Colorado 80045 —
Nemours / Alfred I. DuPont Hospital for Children Wilmington Delaware 19803 —
Nicklaus Children's Hospital Miami Florida 33155 —
Shriners Hospitals for Children-Chicago Chicago Illinois 60707 —
Riley Hospital for Children at Indiana University Health Indianapolis Indiana 46204 —
University of Minnesota Masonic Children's Hospital Minneapolis Minnesota 55454 —
Duke University Medical Center Durham North Carolina 27710 —
Wake Forest Baptist Health Winston-Salem North Carolina 27157 —
Cleveland Clinic Cleveland Ohio 44195 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73110 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
McGovern Medical School at UTHealth Houston Texas 77030 —
Southwest Scoliosis Institute Plano Texas 75075 —
Children's Hospital of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03682302, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 6, 2021 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03682302 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →